We are live on
!
Find out more
VCAM
Valentine Capital Asset Management Portfolio holdings
AUM
$89.6M
1-Year Est. Return
0.84%
This Fund
S&P 500
This Quarter
Est. Return
+3.47%
1 Year Est. Return
-0.84%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$149M
AUM Growth
-$194M
(-57%)
Cap. Flow
-$200M
Cap. Flow
% of AUM
-134.85%
Top 10 Holdings %
Top 10 Hldgs %
29.41%
Holding
99
New
4
Increased
–
Reduced
72
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
|
+$3.03M |
| 2 |
Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033
GLDI
|
+$2.97M |
| 3 |
ConocoPhillips
COP
|
+$2.68M |
| 4 |
OKS
Oneok Partners LP
OKS
|
+$297K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares UltraPro Short S&P 500
SPXU
|
+$14.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$9.85M |
| 3 |
SWIR
Sierra Wireless
SWIR
|
+$7.05M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$5.56M |
| 5 |
Lowe's Companies
LOW
|
+$4.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.44% |
| 2 | Consumer Discretionary | 10.04% |
| 3 | Technology | 8% |
| 4 | Energy | 7.37% |
| 5 | Communication Services | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TARO
1
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $6.23M | 4.19% |
43,343
-32,680
| -43% | -$4.66M |
|
2
ProShares Ultra NASDAQ Biotechnology
BIB
$84.4M
| $5.33M | 3.59% |
58,980
-50,216
| -46% | -$4.32M |
|
3
Ambarella
AMBA
$3.03B
| $5.32M | 3.58% |
51,800
-43,894
| -46% | -$3.84M |
|
4
iShares China Large-Cap ETF
FXI
$4.27B
| $4.53M | 3.05% |
98,355
-83,450
| -46% | -$4.13M |
|
5
Direxion Daily Financial Bull 3x ETF
FAS
$2.52B
| $4.39M | 2.95% |
140,143
-110,705
| -44% | -$3.55M |
|
6
Jazz Pharmaceuticals
JAZZ
$16.1B
| $3.92M | 2.63% |
22,240
-19,386
| -47% | -$3.48M |
|
7
Chevron
CVX
$374B
| $3.69M | 2.49% |
38,300
-41,127
| -52% | -$4.32M |
|
8
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $3.52M | 2.36% |
41,820
-36,060
| -46% | -$2.8M |
|
9
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.85B
| $3.4M | 2.29% |
27,455
-20,990
| -43% | -$2.53M |
|
|
IFN
10
Aberdeen India Fund
IFN
$496M
| $3.4M | 2.29% |
128,429
-108,414
| -46% | -$2.91M |
|
11
Omega Healthcare
OHI
$15.4B
| $3.38M | 2.27% |
98,330
-80,846
| -45% | -$2.97M |
|
12
B&G Foods
BGS
$297M
| $3.16M | 2.13% |
110,775
-99,375
| -47% | -$2.98M |
|
13
iShares MSCI Hong Kong ETF
EWH
$1.24B
| $2.96M | 1.99% |
131,240
-104,048
| -44% | -$2.46M |
|
|
14
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
$11.1M
| $2.92M | 1.96% |
+13,380
| New | +$3.03M |
|
|
15
Credit Suisse X-Links Gold Shares Covered Call ETNs due February 2 2033
GLDI
$30.9M
| $2.92M | 1.96% |
+12,617
| New | +$2.97M |
|
16
Precigen
PGEN
$1.97B
| $2.88M | 1.94% |
59,531
-54,519
| -48% | -$2.3M |
|
17
Walt Disney
DIS
$172B
| $2.83M | 1.91% |
24,823
-19,621
| -44% | -$2.15M |
|
|
AFSI
18
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $2.82M | 1.9% |
86,200
-64,400
| -43% | -$1.94M |
|
|
SVC
19
Service Properties Trust
SVC
$1.09B
| $2.8M | 1.89% |
19,585
-15,930
| -45% | -$2.42M |
|
20
iShares Core MSCI Emerging Markets ETF
IEMG
$147B
| $2.75M | 1.85% |
69,415
-55,545
| -44% | -$2.81M |
|
21
ProShares Ultra Energy
DIG
$77.4M
| $2.75M | 1.85% |
45,667
-40,964
| -47% | -$2.74M |
|
22
Direxion Daily MSCI India Bull 2X ETF
INDL
$56M
| $2.55M | 1.71% |
32,088
-41,347
| -56% | -$3.06M |
|
|
23
ConocoPhillips
COP
$139B
| $2.52M | 1.7% |
+41,123
| New | +$2.68M |
|
|
AKRX
24
DELISTED
Akorn Inc
AKRX
| $2.49M | 1.68% |
57,100
-51,300
| -47% | -$2.37M |
|
|
FL
25
DELISTED
Foot Locker
FL
| $2.49M | 1.68% |
37,176
-30,351
| -45% | -$1.89M |
|
Similar funds
TSBJ
TP
SPC
DA
KCA
CCM
ST
HCM
Valentine Capital Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Valentine Capital Asset Management held 99 positions worth $149M, down 57% from $342M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Valentine Capital Asset Management withdrew a net $200M in Q2 2015, closing 23 positions and reducing 72 holdings. Its most notable exit was ProShares UltraPro Short S&P 500, an estimated $14.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Valentine Capital Asset Management opened a new position in Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033 worth $2.92M.
- Valentine Capital Asset Management's largest Q2 2015 buy was Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033: 13,380 shares worth $2.92M.
- Valentine Capital Asset Management's biggest Q2 2015 reduction was Taro Pharmaceutical Industries Ltd., cutting an estimated $4.66M.
- Valentine Capital Asset Management fully exited ProShares UltraPro Short S&P 500 in Q2 2015, selling an estimated $14.6M.
- Valentine Capital Asset Management's ten largest holdings make up 29% of its $149M portfolio in Q2 2015.
- Valentine Capital Asset Management opened 4 new positions and closed 23 in Q2 2015.
- Valentine Capital Asset Management's portfolio value fell 57% quarter-over-quarter to $149M.
Based on Valentine Capital Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.